RG-201

• Description :

  RG-201 can be studied in research on Pneumocystis carinii pneumonia[1].

• UNSPSC :

  12352005

• Target :

  Biochemical Assay Reagents

• Related Pathways :

  Others

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Smiles :

  C1(CCCCC2=NC3=CC=C(C4=NCCN4)C=C3N2)=NC5=CC=C(C6=NCCN6)C=C5N1

• Molecular Formula :

  C24H26N8

• Molecular Weight :

  426.52

• References & Citations :

  [1]Doepel L. K. (1995) . Drug developed by NCDDG-OI to enter clinical trials. National Cooperative Drug Discovery Group Program for Opportunistic Infections. NIAID AIDS agenda, 9.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [148344-24-5]